United States

People: Alkermes Plc (ALKS.O)

ALKS.O on Nasdaq

9:30am EDT
Change (% chg)

$-0.03 (-0.05%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Cooke, Shane 

Mr. Shane Cooke is President of the Company. Mr. Cooke is employed by Alkermes Pharma Ireland Limited, an Irish subsidiary of the Company. From May 2005 to September 16, 2011, Mr. Cooke served as a Director of Elan Corporation, plc (“Elan”). From May 2007 to September 16, 2011, Mr. Cooke was Executive Vice President of Elan and Head of Elan Drug Technologies. Mr. Cooke served as the Chief Financial Officer of Elan from July 2001, when he joined Elan, until May 2011. Prior to joining Elan, Mr. Cooke was Chief Executive of Pembroke Capital Limited, an aviation leasing company, and prior to that, held a number of senior positions in finance in the banking and aviation industries. He is a chartered accountant. He is currently on the board of directors of Prothena Biosciences and Prothena Therapeutics, both subsidiaries of publicly traded Prothena Corporation plc, as well as Endo International plc, a publicly traded company.

Basic Compensation

Total Annual Compensation, USD 561,847
Restricted Stock Awards, USD 903,560
Long-Term Incentive Plans, USD --
All Other, USD 2,679,460
Fiscal Year Total, USD 4,144,870

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Richard Pops


Shane Cooke


James Frates


Kathryn Biberstein


Elliot Ehrich


Iain Brown

As Of  30 Dec 2016